Rtor number: rtor-CSF-0005 acquisition of colony stimulating factor(S) (G-CSF or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation
Ended Awarded Last action
- Contract number
- 75A50118F33004
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493 Part of Amgen Inc.
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $154,444,070
Award facts
- Opportunity
-
- 12100SOL00016 Solicitation number
- Contract value 100% obligated
-
- $154,444,070.38 Current, with exercised options
- $154,445,489.12 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Thousand Oaks, CA 91320, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $49,520 | |
| Original award | $154,394,550 |
About this award
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Amgen USA Inc., a subsidiary of Amgen Inc., to provide a colony stimulating factor (G-CSF or GM-CSF) as a medical countermeasure for mitigating neutropenia arising from exposure to ionizing radiation. The contract is a $154,445,489.12 firm fixed price delivery order under the HHS Colony Stimulating Factor 2013-2018 indefinite delivery contract. The award does not have a set-aside designation and the period of performance runs through March 12, 2024. Amgen is the prime contractor and no subcontractors are mentioned. This contract supports the agency's efforts to acquire critical medical countermeasures to address potential radiation exposure incidents.
Quick answers
Who was awarded contract 75A50118F33004?
75A50118F33004 was awarded to Amgen USA Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 13, 2018.
How much is contract 75A50118F33004 worth?
The government has obligated $154,444,070 on 75A50118F33004. Its potential value, with all options, is $154,445,489.
Is contract 75A50118F33004 an order under another contract?
Yes. 75A50118F33004 is a delivery order under HHSO100201300006I, an indefinite delivery contract, on HHS Colony Stimulating Factor 2013-2018.
Was contract 75A50118F33004 competed?
The extent of competition for 75A50118F33004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award